Liquid biopsies in lung cancer: The new ambrosia of researchers

被引:141
作者
Rolfo, Christian [1 ]
Castiglia, Marta [2 ,3 ]
Hong, David [4 ]
Alessandro, Riccardo [5 ]
Mertens, Inge [6 ,7 ]
Baggerman, Geert [6 ,7 ]
Zwaenepoel, Karen [2 ]
Gil-Bazo, Ignacio [8 ]
Passiglia, Francesco [1 ,3 ]
Carreca, Anna P. [1 ,2 ]
Taverna, Simona [5 ]
Vento, Renza [9 ]
Peeters, Marc [10 ]
Russo, Antonio [3 ]
Pauwels, Patrick [2 ]
机构
[1] Univ Antwerp Hosp, Dept Oncol, Phase Early Clin Trials Unit 1, B-2650 Edegem, Belgium
[2] Univ Antwerp Hosp, Dept Pathol, Mol Pathol Unit, B-2650 Edegem, Belgium
[3] Univ Palermo, Sect Med Oncol, Dept Surg Oncol & Oral Sci, I-90127 Palermo, Italy
[4] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Program 1, Houston, TX 77030 USA
[5] Univ Palermo, Sect Biol & Genet, Dept Biopathol & Med & Forens Biotechnol, I-90133 Palermo, Italy
[6] VITO, Ctr Prote, BE-2400 Mol, Belgium
[7] Univ Antwerp, B-2020 Antwerp, Belgium
[8] Univ Navarra Clin, Dept Oncol, Lung Canc Unit, Pamplona 31008, Spain
[9] Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol, Biochem Lab, I-90128 Palermo, Italy
[10] Univ Antwerp Hosp, Dept Oncol, B-2650 Edegem, Belgium
来源
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 2014年 / 1846卷 / 02期
关键词
Circulating tumor cells; Exosomes; Circulating tumor DNA; Lung cancer; Biomarkers; CIRCULATING TUMOR-CELLS; FREE DNA; BIOMARKER DISCOVERY; PANCREATIC-CANCER; DIAGNOSTIC MARKER; PROTEOME ANALYSIS; PERIPHERAL-BLOOD; PROGNOSTIC VALUE; PROGRESSION-FREE; EGFR MUTATIONS;
D O I
10.1016/j.bbcan.2014.10.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the last decades the approach to cancer patient management has been deeply revolutionized. We are moving from a "one-fits-all" strategy to the "personalized medicine" based on the molecular characterization of the tumor. In this new era it is becoming more and more clear that the monitoring of the disease is fundamental for the success of the treatment, thus there is the need of new biomarker discovery. More precisely in the last years the scientific community has started to use the term "liquid biopsy". A liquid biopsy is a liquid biomarker that can be easily isolated from many body fluids (blood, saliva, urine, ascites, pleural effusion, etc.) and, as well as a tissue biopsy, a representative of the tissue from which it is spread. In this review we will focus our attention on circulating tumor cells, circulating tumor DNA, exosomes and secretomes with the aim to underlie their usefulness and potential application in a clinical setting for lung cancer patient management. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:539 / 546
页数:8
相关论文
共 85 条
[11]   Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases [J].
Chen, Xi ;
Ba, Yi ;
Ma, Lijia ;
Cai, Xing ;
Yin, Yuan ;
Wang, Kehui ;
Guo, Jigang ;
Zhang, Yujing ;
Chen, Jiangning ;
Guo, Xing ;
Li, Qibin ;
Li, Xiaoying ;
Wang, Wenjing ;
Zhang, Yan ;
Wang, Jin ;
Jiang, Xueyuan ;
Xiang, Yang ;
Xu, Chen ;
Zheng, Pingping ;
Zhang, Juanbin ;
Li, Ruiqiang ;
Zhang, Hongjie ;
Shang, Xiaobin ;
Gong, Ting ;
Ning, Guang ;
Wang, Jun ;
Zen, Ke ;
Zhang, Junfeng ;
Zhang, Chen-Yu .
CELL RESEARCH, 2008, 18 (10) :997-1006
[12]  
Chen XQ, 1999, CLIN CANCER RES, V5, P2297
[13]   Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer [J].
Chen, Yue ;
Zhang, Hao ;
Xu, Anjian ;
Li, Na ;
Liu, Jifu ;
Liu, Chuanjun ;
Lv, Dongxia ;
Wu, Shanshan ;
Huang, Lingyun ;
Yang, Shuanying ;
He, Dacheng ;
Xiao, Xueyuan .
LUNG CANCER, 2006, 54 (01) :95-102
[14]   Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer [J].
Cohen, Steven J. ;
Punt, Cornelis J. A. ;
Iannotti, Nicholas ;
Saidman, Bruce H. ;
Sabbath, Kert D. ;
Gabrail, Nashat Y. ;
Picus, Joel ;
Morse, Michael ;
Mitchell, Edith ;
Miller, M. Craig ;
Doyle, Gerald V. ;
Tissing, Henk ;
Terstappen, Leon W. M. M. ;
Meropol, Neal J. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (19) :3213-3221
[15]   Exosomes as Intercellular Signaling Organelles Involved in Health and Disease: Basic Science and Clinical Applications [J].
Corrado, Chiara ;
Raimondo, Stefania ;
Chiesi, Antonio ;
Ciccia, Francesco ;
De Leo, Giacomo ;
Alessandro, Riccardo .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (03) :5338-5366
[16]   Identification of Somatic Genomic Alterations in Circulating Tumors Cells: Another Step Forward in Non-Small-Cell Lung Cancer? [J].
Costa, Daniel B. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (18) :2236-U31
[17]   Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes [J].
Crescitelli, Rossella ;
Lasser, Cecilia ;
Szabo, Tamas G. ;
Kittel, Agnes ;
Eldh, Maria ;
Dianzani, Irma ;
Buzas, Edit I. ;
Lotvall, Jan .
JOURNAL OF EXTRACELLULAR VESICLES, 2013, 2 (01)
[18]   Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer [J].
Danila, Daniel C. ;
Heller, Glenn ;
Gignac, Gretchen A. ;
Gonzalez-Espinoza, Rita ;
Anand, Aseem ;
Tanaka, Erika ;
Lilja, Hans ;
Schwartz, Lawrence ;
Larson, Steven ;
Fleisher, Martin ;
Scher, Howard I. .
CLINICAL CANCER RESEARCH, 2007, 13 (23) :7053-7058
[19]   Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer [J].
Dawson, Sarah-Jane ;
Tsui, Dana W. Y. ;
Murtaza, Muhammed ;
Biggs, Heather ;
Rueda, Oscar M. ;
Chin, Suet-Feung ;
Dunning, Mark J. ;
Gale, Davina ;
Forshew, Tim ;
Mahler-Araujo, Betania ;
Rajan, Sabrina ;
Humphray, Sean ;
Becq, Jennifer ;
Halsall, David ;
Wallis, Matthew ;
Bentley, David ;
Caldas, Carlos ;
Rosenfeld, Nitzan .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (13) :1199-1209
[20]   Contribution of proteomics to understanding the role of tumor-derived exosomes in cancer progression: State of the art and new perspectives [J].
Fontana, Simona ;
Saieva, Laura ;
Taverna, Simona ;
Alessandro, Riccardo .
PROTEOMICS, 2013, 13 (10-11) :1581-1594